Refine/Revise Search
Asking Price: $199,000

Home Health Care Management

Not Disclosed, CA
San diego County

California Licensed Non-Medical In-Home Care-Life Care Management company.This company was founded in 2009. Company has specialized in the total care oversight of frail older adults. Service offerings have included: Life Care Management, Non-medical Home Care Aides and Referral and placement.Care Management includes; assessment and care planning, on-going care coordination by touching the physical, mental, social and spiritual needs of clients. The life care manager serves as liaison and advocate between the client, family and healthcare providers.Non-Medical Home Care Aides: Offers both companion and personal care services in the client home. Services range from light housekeeping, errands, meal preparation to hands on assistance. Which includes activities of daily living such as grooming and hygiene to full end of life care. The care aides can service can range from 2-3 hours to 24 hour live in care.Referral and Placement: Referral fee paid by contracted retirement living facilities. This is a Free service to assist clients and families in securing suitable retirement living which is customized to their individual needs. Currently 13 clients are receiving inhome care. In addition, the company has 13 active field employees others available as needed. Owner works full time in the business and wants to explore other opportunities.Appropriate for home based operation (assuming a 3rd party office for occasional meetings) or fold into existing operation. This is not appropriate for individuals not already experienced in the business.Projected 2019 Revenue $700k, potential earnings $150k (assumes home based with owner - operator). Company restructured early 2019 so historic data, though available is no longer relevant. Asking Price is $199,000.

Cash Flow $150,000
Revenue $700,000
$ Owner Financing Available

Asking Price: $20,000,000

Patented Universal Tumor-Targeting Drug Delivery

Irvine, CA
Orange County

Patented Universal Tumor-Targeting Drug Delivery Platform Co.This pharmaceutical company has developed and patented a universal tumor-targeting drug-delivery platform that can improve the safety and efficacy of many existing chemo treatments, with the ability to target numerous different types of cancer. The technology encapsulates existing FDA-approved drugs inside lipid nanoparticles (liposomes or emulsions) coated with patented human-sourced antinuclear antibodies (ANA). The lipid nanoparticle provides long-term storage stability of the drug and controlled release of the drug over time at body-temperature, and is expected to improve the safety and efficacy profile of the drug, including passive accumulation at the tumor while not harming normal tissues. The Company’s ANA, sourced from lupus patients, binds to nuclear material present in abundance in areas of necrosis (dead / ruptured cells) present in and around all solid tumors, thus anchoring the drug-filled nanoparticles at the tumor where the nanoparticle is designed to slowly release the drug directly on the tumor for more effect. As the Company’s ANA is not tumor-marker specific, but rather targets necrosis present in solid tumors, the technology is designed to 'universally' target many different types of cancer including breast cancer, lung, ovarian, colon, prostate, etc., as well as rare childhood cancers.The Company completed a successful proof-of-concept study at Children's Hospital using Ewing's Sarcoma transplanted in immunodeficient mice. Treatment with the Company's forumlation significantly inhibited tumor growth and extended survival times compared to control mice receiving no treatment or treatment with plain liposomal doxorubicin.The Company has been granted Orphan Drug Designation by the FDA on 2 of the lead drug formulations, providing FDA fee waivers, priority review, and 7-years exclusivity upon market approval. The orphan pathway also enables the potential for New Drug Approval after successful completion of Phase 2 studies, with Phase III data collected while in the market, thus significantly lowering the time and cost to market approval. This same drug inside the Company's tumor targeting delivery system will likely have potential to treat other pediatric cancers, and/or cancers in larger adult populations.As the Company’s platform and ANA has the potential to improve the safety and efficacy of many existing FDA approved drugs or even compounds in development, the Company anticipates the potential for multiple licensing agreements with multiple pharmaceutical companies seeking to improve their existing portfolio and extend patient life as they advance into clinical stage. And as it may be possible to file for New Drug Approval following successful Phase II studies, the Company anticipates licensing potential at early clinical stage. Multiple exit opportunities exist with high impact & high ROI.The Company is seeking a supportive capital partner to maintain momentum up to $20M. Funding will be used to advance the lead drug through formal Investigational New Drug enabling studies towards New Drug Approval; estimating $3-5 Million now to advance into clinical studies. Preclinical / animal studies estimate ($3 - 5 Million and 12-18 months); followed by potential combined Phase I-II clinical study in a rare cancer (approximately 2-3 years and $10M) to potential New Drug Approval, plus additional capital to advance additional drugs in the pipeline simultaneously, thus adding tremendous value to the Company’s valuation. Valuations of pharma companies often exceed $100 Million valuation at Phase I (approximately 18 months), and New Drug Approval can exceed valuations above $1 Billion. The Company has numerous, improved high-impact cancer drugs advancing with proper support.NDA is required for comprehensive Confidential Information Memorandum crafted by ProNova Partners.

Cash Flow Not Disclosed
Revenue Not Disclosed
$ Owner Financing Available

Asking Price: $299,000

Renovation Design, Build, Retail & Wholesale Biz

Dallas, TX
Dallas County

Full service renovation company that offers Interior Decorating, Renovation and Decorating Showroom combined with a Retail presence allowing for a truly vertical business model. *Retail/Wholesale - This business provides full turnkey services: Home decor and furniture products, kitchen and bathroom, cabinets, flooring, plumbing and lighting fixtures, variety of counter top options and more. *Services - Interior design and renovation/installation services out of a comfortable storefront that also generates walk in traffic.*The showroom offers legitimacy to the business that an office suite or working from a home office does not. Potential clients feel more comfortable and at ease knowing that there is a store location that makes them feel that they are truly working with a sound, established business compared to other contractors the business competes against. *Successful business model:Proven systems that have been in operation since 2001. Operations and marketing expertise will be transferred (which allowed this operation to be successful every year of operation). In 2017 the business will do over a million and 2016 was just under that. This operation does not do a large amount of projects, but rather does larger projects to maximize efficiency and minimizing churn. Specializing in whole house design and remodels the second best money makers pursued are kitchens and baths. As the operation sells the products that are used in these renovations (both wholesale and retail to the contractor base/general public), the gross profit margin is 20% higher than that of other, competing contractors. *Even an existing contracting operation could benefit from the purchase of this business for the proven processes and pipeline of upcoming business. As this business has the ability to purchase direct as a wholesaler from the manufactures, this nets higher profit margins on all materials used on every project. *Wholesaling - On the wholesaling front, the showroom offers a location where a 3rd party contractor or Interior designor to make all of their project selections at one location without having to waste time traveling to independent stores to individually select each and every product for projects.

Cash Flow $242,198
Revenue $1,100,000

Asking Price: $215,000

Fast Casual Franchise Restaurant - Part-Time Owner

Irving, TX
Dallas County

Why This Opportunity – This Franchised Restaurant is the future of quick, casual food service. People are changing the way they eat—they want something unique and healthy—and this franchise delivers in an innovative way.This franchiser has created an entire culture and a proven franchising system—one that has undergone twenty years of fine tuning—to meet this growing demand. The unique combination of fresh, healthy food, mainstream music, and a lot of fun—along with young, high-energy staff members and customers, creates the very unique lively vibe. Today, there are more than 240 locations in the United States, and over 580 locations worldwide—the company is poised for explosive growth.The franchisees not only benefit from proven business model and support, but also from knowing that they are invested in a business that is a source of pride, as well as a profit. In 2015 the franchise was ranked #32 in Entrepreneur Magazine's list of America's Top Global Franchises and #16 in Business Insider's Top 20 Food Franchises in the World! It's a very exciting time to be a franchisee.4.3 Star Rating from 83 Google Reviews. All FF&E is brand new (purchased 2015 when restaurant opened) and included in asking price!Patio space already approved for use. It would be advantageous for new owner to take that opportunity & increase seating capacity for extra revenue.

Cash Flow $87,091
Revenue $360,821

loading...
TOP â–²
Add Businesses and/or Franchises
To Basket For Free Information

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.